Niagen Bioscience, Inc. (NAGE): R&D Expense
$6.33M
Year ended 2025-12-31
$6.50M
Trailing 12 months to 2026-06-30
+9.5%
3-year compound annual growth
+13.1%
5-year compound annual growth
| Period ended | R&D Expense | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $6.33M | +5.2% | 2026-03-04, From 2025-01-01 |
| 2024-12-31 | $6.02M | +21.3% | 2026-03-04, From 2024-01-01 |
| 2023-12-31 | $4.96M | +2.7% | 2025-03-04, From 2023-01-01 |
| 2022-12-31 | $4.83M | +25.9% | 2024-03-06, From 2022-01-01 |
| 2021-12-31 | $3.83M | +12.2% | 2023-03-08, From 2021-01-01 |
| 2020-12-31 | $3.42M | n/c | 2022-03-14, From 2020-01-01 |
| 2019-12-31 | $4.42M | -19.3% | 2021-03-12, From 2019-01-01 |
| 2018-12-31 | $5.48M | +36.7% | 2020-03-10, From 2017-12-31 |
| 2017-12-30 | $4.01M | +58.8% | 2019-03-07, From 2017-01-01 |
| 2016-12-31 | $2.52M | +182.9% | 2018-03-15, From 2016-01-03 |
| 2016-01-02, Fiscal 2015 | $891.6K | +73.6% | 2018-03-15, From 2015-01-04 |
| 2015-01-03, Fiscal 2014 | $513.7K | +283.2% | 2017-03-16, From 2013-12-29 |
| 2013-12-28 | $134.0K | -5.6% | 2016-03-17, From 2012-12-30 |
| 2012-12-29 | $142.0K | +46.7% | 2014-03-27, From 2012-01-01 |
| 2011-12-31 | $96.8K | n/a | 2013-03-29, From 2011-01-02 |
R&D Expense at similar companies
| Company | Year ended | R&D Expense | Change YoY |
|---|---|---|---|
| Niagen Bioscience, Inc. (NAGE) | 2025-12-31 | $6.33M | +5.2% |
| Natural Alternatives International Inc (NAII) | 2025-06-30 | $1.80M | -5.3% |
| Cronos Group Inc. (CRON) | 2025-12-31 | $4.45M | +5.2% |
| Mannatech Inc (MTEX) | 2025-12-31 | $800.0K | +14.3% |
| Leef Brands Inc. (LEEEF) | 2025-12-31 | $19.7K | +3.8% |
| Cyanotech Corp (CYAN) | 2025-03-31 | $449.0K | -34.8% |
| Bon Natural Life Ltd (BON) | 2025-09-30 | $754.2K | -53.5% |
| Tilray Brands, Inc. (TLRY) | 2026-05-31 | $361.0K | +27.1% |
| USANA Health Sciences Inc (USNA) | 2026-01-03 | $10.69M | -7.6% |
Compare NAGE, NAII, CRON, MTEX side by side · Screen every company in Medicinal Chemicals & Botanical Products ↗